During the past decade, MSD Korea LTD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MSD Korea LTD" are "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Anal Cancer" (1 trials), "Anal Carcinoma" (1 trials) and "Bile Duct Cancer" (1 trials). Many other conditions were trialed in "MSD Korea LTD" in a lesser frequency.

Most popular intervention types in "MSD Korea LTD" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (1 trials), "Test Meal" (1 trials) and "pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "MSD Korea LTD" are 3 trials for "All" genders.

Currently, there are NaN active trials in "MSD Korea LTD". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MSD Korea LTD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MSD Korea LTD, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".